Alan R. Crossman

Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primate

Tipu Z. Aziz, David Peggs, M.A. Sambrook et al. · Movement Disorders · 1991 · 538 citations

Life Sciences, Neurology, Neuroscience +15

Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease

Erwan Bézard, Sandra Doveró, Caroline Prunier et al. · Journal of Neuroscience · 2001 · 481 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Ian Mitchell, Carl E Clarke, S. Boyce et al. · Neuroscience · 1989 · 459 citations

Life Sciences, Neurobiology, Neuroscience +16

Cannabinoids reduce levodopa-induced dyskinesia in Parkinson’s disease: A pilot study

Katarzyna Sieradzan, Susan H. Fox, Michael P. Hill et al. · Neurology · 2001 · 347 citations

Medicine, Pharmacology, Pharmacotherapy +17

Nucleus tegmenti pedunculopontinus: Efferent connections with special reference to the basal ganglia, studied in the rat by anterograde and retrograde transport of horseradish peroxidase

Alan R. Crossman · Neuroscience · 1983 · 308 citations

Life Sciences, Neurobiology, Neuroscience +15